Activity-dependent regulation of tyrosine hydroxylase expression in the enteric nervous system

Journal of Physiology

Volumn 586, Issue 7, 2008, Pages 1963-1975

  Chevalier, J ^a,b,c   Derkinderen, P ^a,b,c   Gomes, P ^d   Thinard, R ^a   Naveilhan, P ^a   Vanden Berghe, P ^d   Neunlist, M ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CLONIDINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; HEXAMETHONIUM; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; POTASSIUM CHLORIDE; PROTEIN KINASE C; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; TYROSINE 3 MONOOXYGENASE; VERATRIDINE; ALPHA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINIC RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; CALCIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE METABOLISM; ELECTRIC FIELD; EMBRYONAL TISSUE; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ADRENERGIC SYSTEM; CALCIUM TRANSPORT; CHOLINERGIC SYSTEM; ELECTROSTIMULATION; EMBRYO; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; INNERVATION; INTESTINE; METABOLISM; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTRIC STIMULATION; ENTERIC NERVOUS SYSTEM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTESTINES; NEURONS; POTASSIUM CHLORIDE; PREGNANCY; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE; VERATRIDINE;

EID: 45549091413     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.149815     Document Type: Article

References (51)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT & Saltiel AR (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494.
2. Anlauf M, Schafer MK, Eiden L & Weihe E (2003). Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 459, 90-111.
3. Baldassa S, Zippel R & Sturani E (2003). Depolarization- induced signaling to Ras, Rap1 and MAPKs in cortical neurons. Brain Res Mol Brain Res 119, 111-122.
4. Belai A, Boulos PB, Robson T & Burnstock G (1997). Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 40, 767-774.
5. Brosenitsch TA & Katz DM (2001). Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels. J Neurosci 21, 2571-2579.
6. Brosenitsch TA, Salgado-Commissariat D, Kunze DL & Katz DM (1998). A role for L-type calcium channels in developmental regulation of transmitter phenotype in primary sensory neurons. J Neurosci 18, 1047-1055.
7. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T & Hidaka H (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N -[2-(p -bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265, 5267-5272.
8. Cigola E, Volpe BT, Lee JW, Franzen L & Baker H (1998). Tyrosine hydroxylase expression in primary cultures of olfactory bulb: Role of L-type calcium channels. J Neurosci 18, 7638-7649.
9. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR & Lee JC (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229-233.
10. Curtis J & Finkbeiner S (1999). Sending signals from the synapse to the nucleus: Possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J Neurosci Res 58, 88-95.
11. Derkinderen P, Enslen H & Girault JA (1999). The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10, R24-R34.
12. Du Z, Guo X & Iacovitti L (1998). Regulation of tyrosine hydroxylase gene expression during transdifferentiation of striatal neurons: Changes in transcription factors binding the AP-1 site. J Neurosci 18, 8163-8174
13. Eaker EY, Bixler GB, Dunn AJ, Moreshead WV & Mathias JR (1988). Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins. J Pharmacol Exp Ther 244, 438-442.
14. Gershon MD, Chalazonitis A & Rothman TP (1993). From neural crest to bowel: Development of the enteric nervous system. J Neurobiol 24, 199-214.
15. Goyal RK & Hirano I (1996). The enteric nervous system. N Engl J Med 334, 1106-1115.
16. Grewal SS, Horgan AM, York RD, Withers GS, Banker GA & Stork PJ (2000). Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J Biol Chem 275, 3722-3728.
17. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA & Connelly PA (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271, 695-701.
18. Haslam RJ, Davidson MM & Desjardins JV (1978). Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176, 83-95.
19. Kelles A, Janssens J & Tack J (2000). IL-1β and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig. Neurogastroenterol Motil 12, 531-538.
20. Khen N, Jaubert F, Sauvat F, Fourcade L, Jan D, Martinovic J, Vekemans M, Landais P, Brousse N, Leborgne M, Nihoul-Fekete C, Cerf-Bensussan N & Sarnacki S (2004). Fetal intestinal obstruction induces alteration of enteric nervous system development in human intestinal atresia. Pediatr Res 56, 975-980.
21. Kilbourne EJ, Nankova BB, Lewis EJ, McMahon A, Osaka H, Sabban DB & Sabban EL (1992). Regulated expression of the tyrosine hydroxylase gene by membrane depolarization. Identification of the responsive element and possible second messengers. J Biol Chem 267, 7563-7569.
22. 2+ channel a1 subunits in the enteric nervous system: presence of a1B channel-like immunoreactivity in intrinsic primary afferent neurons. J Comp Neurol 409, 85-104.
23. 3H]acetylcholine release from guinea-pig stomach. J Pharmacol Exp Ther 234, 713-719.
24. Li ZS, Pham TD, Tamir H, Chen JJ & Gershon MD (2004). Enteric dopaminergic neurons: Definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 24, 1330-1339.
25. Li ZS, Schmauss C, Cuenca A, Ratcliffe E & Gershon MD (2006). Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 26, 2798-2807.
26. T method. Methods 25, 402-408.
27. Milosevic J, Brandt A, Roemuss U, Arnold A, Wegner F, Schwarz SC, Storch A, Zimmermann H & Schwarz J (2006). Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: Involvement of MEK/ERK signalling. J Neurochem 99, 913-923.
28. Neunlist M, Aubert P, Toquet C, Oreshkova T, Barouk J, Lehur PA, Schemann M & Galmiche JP (2003). Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52, 84-90.
29. Nishizaki K, Nakao K, Ishii H, Yamanaka H, Tokunaga A, Nakagawa K, Yamamura T & Noguchi K (2003). Induction of neuronal nitric oxide synthase by sympathetic denervation is mediated via a2-adrenoceptors in the jejunal myenteric plexus. Brain Res 965, 121-129.
30. Otten U & Thoenen H (1976). Mechanisms of tyrosine hydroxylase and dopamine β-hydroxylase induction in organ cultures of rat sympathetic ganglia by potassium depolarization and cholinomimetics. Naunyn Schmiedebergs Arch Pharmacol 292, 153-159.
31. Pham TD, Gershon MD & Rothman TP (1991). Time of origin of neurons in the murine enteric nervous system: Sequence in relation to phenotype. J Comp Neurol 314, 789-798.
32. Rehn M, Hubschle T & Diener M (2004). TNF-α hyperpolarizes membrane potential and potentiates the response to nicotinic receptor stimulation in cultured rat myenteric neurones. Acta Physiol Scand 181, 13-22.
33. Roberts RR, Murphy JF, Young HM & Bornstein JC (2007). Development of colonic motilty in the neonatal mouse - studies using spatiotemporal maps. Am J Physiol Gastrointest Liver Physiol 292, G93013-G938.
34. Sann H, Hoppe S, Baldwin L, Grundy D & Schemann M (1998). Presence of putative neurotransmitters in the myenteric plexus of the gastrointestinal tract and in the musculature of the urinary bladder of the ferret. Neurogastroenterol Motil 10, 35-47.
35. 2+ channels in isolated ganglia from the myenteric plexus. Life Sci 77, 2489-2499.
36. 2A -adrenoceptor-deficient mice. Br J Pharmacol 135, 697-704.
37. Schemann M & Neunlist M (2004). The human enteric nervous system. Neurogastroenterol Motil 16 (Suppl. 1), 55-59.
38. Schemann M, Schaaf C & Mader M (1995). Neurochemical coding of enteric neurons in the guinea pig stomach. J Comp Neurol 353, 161-178.
39. Schneider J, Jehle EC, Starlinger MJ, Neunlist M, Michel K, Hoppe S & Schemann M (2001). Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol Motil 13, 255-264.
40. Shah P, Nankova BB, Parab S & La Gamma EF (2006). Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein. Brain Res 1107, 13-23.
41. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R & Quigley EM (1995). Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 346, 861-864.
42. Spitzer NC, Borodinsky LN & Root CM (2005). Homeostatic activity-dependent paradigm for neurotransmitter specification. Cell Calcium 37, 417-423.
43. Sun B, Sterling CR & Tank AW (2003). Chronic nicotine treatment leads to sustained stimulation of tyrosine hydroxylase gene transcription rate in rat adrenal medulla. J Pharmacol Exp Ther 304, 575-588.
44. Takahashi T, Kurosawa S, Wiley JW & Owyang C (1991). Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs. Gastroenterology 101, 703-710.
45. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-15781.
46. Walker JK, Gainetdinov RR, Mangel AW, Caron MG & Shetzline MA (2000). Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am J Physiol Gastrointest Liver Physiol 279, G311-G318.
47. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X & Greenberg ME (2001). Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A 98, 11024-11031.
48. Xia Y, Hu HZ, Liu S, Ren J, Zafirov DH & Wood JD (1999). IL-1β and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system. J Clin Invest 103, 1309-1316.
49. Young HM, Ciampoli D, Hsuan J & Canty AJ (1999). Expression of Ret-, p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase immunoreactivity by undifferenciated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut. Dev Dyn 216, 137-152.
50. Young HM, Jones BR & McKeown SJ (2002). The projections of early enteric neurons are influenced by the direction of neural crest cell migration. J Neurosci 22, 6005-6018.
51. 3 - secretion in rat late distal colon. Eur J Pharmacol 570, 188-195.